Yali An
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Education
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacy top 2%
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 15
-
- Metabolism, Diabetes, and Cancer 5
- Sphingolipid Metabolism and Signaling 1
- Co-authors
- Qiuhong Gong (30 shared papers)Jinping Wang (22 shared papers)Guangwei Li (25 shared papers)Yinghua Hu (10 shared papers)Ying Shuai (11 shared papers)Peter H. Bennett (7 shared papers)Edward W. Gregg (6 shared papers)Ping Zhang (4 shared papers)
- Journals
- Diabetes Research and Clinical Practice (4 papers)Diabetes Care (4 papers)Diabetes Obesity and Metabolism (3 papers)Journal of Diabetes (2 papers)Diabetes (2 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Yali An
33 papers receiving 1.8k citations
Yali An's Hit Papers
Peers
Comparison fields: 5 of 110
- Endocrinology, Diabetes and Metabolism 860
- Pharmacy 93
- Physiology 314
- Public Health, Environmental and Occupational Health 189
- Pharmacology 106
Countries citing papers authored by Yali An
This map shows the geographic impact of Yali An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali An more than expected).
Fields of papers citing papers by Yali An
This network shows the impact of papers produced by Yali An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali An. The network helps show where Yali An may publish in the future.
Co-authors
The 25 scholars most cited alongside Yali An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study Hit paper breakdown → | 2008 | 1168 |
| 2 | Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study Hit paper breakdown → | 2014 | 453 |
| 3 | 2015 | 73 | |
| 4 | 2021 | 31 | |
| 5 | 2016 | 29 | |
| 6 | 2018 | 18 | |
| 7 | 2022 | 18 | |
| 8 | 2023 | 14 | |
| 9 | 2022 | 12 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 11 | |
| 12 | 2022 | 10 | |
| 13 | 2023 | 9 | |
| 14 | 2022 | 8 | |
| 15 | 2019 | 8 | |
| 16 | 2011 | 7 | |
| 17 | 2019 | 6 | |
| 18 | 2024 | 6 | |
| 19 | [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study]. | 2015 | 6 |
| 20 | 2024 | 5 |
About Yali An
Yali An is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Cardiology and Cardiovascular Medicine, Pollution and Industrial and Manufacturing Engineering, having authored 36 papers that have together received 1.9k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Metabolism, Diabetes, and Cancer (5 papers), Cardiovascular Health and Risk Factors (3 papers), Pharmaceutical and Antibiotic Environmental Impacts (2 papers), Sphingolipid Metabolism and Signaling (1 paper), Obesity, Physical Activity, Diet (1 paper), Water Treatment and Disinfection (1 paper) and Water Quality Monitoring and Analysis (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (860 citations), Pharmacy (93 citations), Physiology (314 citations), Public Health, Environmental and Occupational Health (189 citations) and Pharmacology (106 citations). Yali An has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Qiuhong Gong, Jinping Wang, Guangwei Li, Yinghua Hu, Ying Shuai, Peter H. Bennett, Edward W. Gregg, Ping Zhang, Wenying Yang and Gojka Roglić. Their work appears in journals such as Diabetes Research and Clinical Practice, Diabetes Care, Diabetes Obesity and Metabolism, Journal of Diabetes and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.